<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03823573</url>
  </required_header>
  <id_info>
    <org_study_id>P1102-16</org_study_id>
    <nct_id>NCT03823573</nct_id>
  </id_info>
  <brief_title>Implementation of a Rapid Recovery Protocol in Total Knee Arthroplasty</brief_title>
  <official_title>Prospective Clinical Trial Regarding the Implementation of a Rapid Recovery Protocol in Total Knee Arthroplasty in Rio Hortega University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ignacio Aguado Maestro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital del Río Hortega</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing total knee arthroplasty will follow two different rehabilitation
      protocols. In one of them, they will start walking the day of surgery and discharged on a 48
      hours basis. On the other one, start walking 3 days after surgery and discharged on a 96
      hours basis. Outcomes will be satisfaction, pain, range of movement, incidence of DVT and
      overall complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomization will be performed concealed the day before surgery. Tranexamic acid will be
      used in both groups. Rapid recovery group will not be using a drain, whereas the standard
      protocol group will have one.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 10, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain: Morphine clorhydrate shots requested by the patient</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of shots requested and administered to the patient after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of Motion</measure>
    <time_frame>6 months</time_frame>
    <description>Knee range of motion measured in degrees of flexion (0-180º and extension (0-180º)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ultrasonography incidence of deep vein thrombosis</measure>
    <time_frame>4 weeks-8 weeks</time_frame>
    <description>Incidence of deep vein thrombosis measured by ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall score given by the patient to the knee replacement process</measure>
    <time_frame>6 months</time_frame>
    <description>Satisfaction with the protocol. Subjective measure by the patient from 0 (bad) to 10 (best) with the surgery process.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infection</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of infection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>48 hours</time_frame>
    <description>Haemoglobin drop</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxford Knee Score pre op and post op</measure>
    <time_frame>6 months</time_frame>
    <description>Difference in Oxford Knee Scores postoperatively and preoperatively</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">175</enrollment>
  <condition>Fast Track</condition>
  <condition>Tranexamic Acid Adverse Reaction</condition>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Rapid recovery protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>They will start walking the day of surgery. Levobupivacain 5mg/ml will be placed in the knee tissues. Tranexamic acid inside the knee. No drains.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Classic protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They will start walking 3 days after surgery. Levobupivacain 5 mg/ml will be placed in the femoral nerve. Tranexamic acid inside the knee. A Redon drain will be used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Walk within 24 hours</intervention_name>
    <description>Patients will start walking on different timings. Patients on the rapid recovery protocol won't be using drains.</description>
    <arm_group_label>Classic protocol</arm_group_label>
    <arm_group_label>Rapid recovery protocol</arm_group_label>
    <other_name>Drain</other_name>
    <other_name>Discharge the day after walking</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Knee osteoarthritis willing to undergo total knee arthroplasty

          -  Age 55-79

          -  Consent

        Exclusion Criteria:

          -  Hipersensibility to any of the components used

          -  Epilepsy

          -  Pulmonary embolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitario del Río Hortega</name>
      <address>
        <city>Valladolid</city>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 27, 2019</study_first_submitted>
  <study_first_submitted_qc>January 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2019</study_first_posted>
  <last_update_submitted>April 21, 2020</last_update_submitted>
  <last_update_submitted_qc>April 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital del Río Hortega</investigator_affiliation>
    <investigator_full_name>Ignacio Aguado Maestro</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>fast track</keyword>
  <keyword>total knee arthroplasty</keyword>
  <keyword>tranexamic acid</keyword>
  <keyword>drain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

